Works about SORAFENIB

Results: 1662

Correction: Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1.
Published in:
2025
By:
- Zhao, Jiali;
- Lin, En;
- Bai, Zirui;
- Jia, Yingbin;
- Wang, Bo;
- Dai, Yihua;
- Zhuo, Wenfeng;
- Zeng, Guifang;
- Liu, Xialei;
- Cai, Chaonong;
- Li, Peiping;
- Zou, Baojia;
- Li, Jian
Publication type:
Correction Notice
RPL22L1 fosters malignant features of cervical cancer via the modulation of DUSP6-ERK axis.
Published in:
Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06249-0
By:
- Zhang, Dongmei;
- Zhao, Meiqi;
- Jiang, Ping;
- Zhou, Yunzhen;
- Yan, Xu;
- Zhou, Chong;
- Mu, Yu;
- Xiao, Shan;
- Ji, Guohua;
- Wu, Nan;
- Sun, Donglin;
- Cui, Xiaobo;
- Ning, Shangwei;
- Meng, Hongxue;
- Xiao, Sheng;
- Jin, Yan
Publication type:
Article
Retrospective evaluation of the effect of Ninjin'yoeito in hepatocellular carcinoma patients treated with lenvatinib.
Published in:
Surgery Today, 2022, v. 52, n. 3, p. 441, doi. 10.1007/s00595-021-02358-7
By:
- Toshida, Katsuya;
- Itoh, Shinji;
- Yoshizumi, Tomoharu;
- Shimagaki, Tomonari;
- Wang, Huanlin;
- Kurihara, Takeshi;
- Toshima, Takeo;
- Nagao, Yoshihiro;
- Harada, Noboru;
- Hata, Kojiro;
- Makihara, Yoko;
- Watanabe, Hiroyuki;
- Mori, Masaki
Publication type:
Article
Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma.
Published in:
Surgery Today, 2018, v. 48, n. 4, p. 431, doi. 10.1007/s00595-017-1603-x
By:
- Takeyama, Hideaki;
- Beppu, Toru;
- Higashi, Takaaki;
- Kaida, Takayoshi;
- Arima, Kota;
- Taki, Katsunobu;
- Imai, Katsunori;
- Nitta, Hidetoshi;
- Hayashi, Hiromitsu;
- Nakagawa, Shigeki;
- Okabe, Hirohisa;
- Hashimoto, Daisuke;
- Chikamoto, Akira;
- Ishiko, Takatoshi;
- Tanaka, Motohiko;
- Sasaki, Yutaka;
- Baba, Hideo
Publication type:
Article
Overcoming Hormone Resistance in Breast Cancer Cell Lines: The Impact of Combined Treatment with Sorafenib and Palbociclib on Cell Survival and Proliferation Pathways.
Published in:
Eurasian Journal of Medical Investigation, 2024, v. 8, n. 1, p. 13, doi. 10.14744/ejmi.2023.14963
By:
- Almuradova, Elvina;
- Kahraman, Erkan;
- Goker, Erdem
Publication type:
Article
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors.
Published in:
Eurasian Journal of Medical Investigation, 2022, v. 6, n. 3, p. 326, doi. 10.14744/ejmi.2022.54998
By:
- Paksoy, Nail;
- Ferhatoglu, Ferhat;
- Dogan, Izzet;
- Ak, Naziye;
- Pehlivan, Metin;
- Ekenel, Meltem;
- Basaran, Mert
Publication type:
Article
Crithmum maritimum Improves Sorafenib Sensitivity by Decreasing Lactic Acid Fermentation and Inducing a Pro-Hepatocyte Marker Profile in Hepatocellular Carcinoma.
Published in:
Plant Foods for Human Nutrition, 2023, v. 78, n. 1, p. 230, doi. 10.1007/s11130-022-01037-3
By:
- Gnocchi, Davide;
- Sabbà, Carlo;
- Mazzocca, Antonio
Publication type:
Article
Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection.
Published in:
PeerJ, 2021, p. 1, doi. 10.7717/peerj.12554
By:
- Liming Zheng;
- Xi Gu;
- Guojun Zheng;
- Xin Li;
- Meifang He;
- Longgen Liu;
- Xike Zhou
Publication type:
Article
Synthesis and anti-hepatocellular carcinoma activity of aminopyridinol–sorafenib hybrids.
Published in:
Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 1884, doi. 10.1080/14756366.2021.1953997
By:
- Awasthi, Bhuwan Prasad;
- Chaudhary, Prakash;
- Guragain, Diwakar;
- Jee, Jun-Goo;
- Kim, Jung-Ae;
- Jeong, Byeong-Seon
Publication type:
Article
Treatment of Intermediate/Advanced Hepatocellular Carcinoma in the Clinic: How Can Outcomes Be Improved?
Published in:
Oncologist, 2010, v. 15, p. 42, doi. 10.1634/theoncologist.2010-S4-42
By:
- Lencioni, Riccardo;
- Chen, Xiao-Ping;
- Dagher, Lucy;
- Venook, Alan P.
Publication type:
Article
Amygdalin Enhances the Antitumor Effect of Sorafenib.
Published in:
Egyptian Academic Journal of Biological Sciences. D, Histology & Histochemistry, 2021, v. 13, n. 2, p. 61, doi. 10.21608/EAJBSD.2021.196336
By:
- Elmetwalli, Alaa;
- Abdel Khalek, Aya M.;
- El-Naggar, Sabry A.;
- El- Magd, Mohammed A.;
- Salama, Afrah F.
Publication type:
Article
А SORAFENIB INDUCED MODEL OF GLOMERULAR KIDNEY DISEASE.
Published in:
Bulletin of Taras Shevchenko National University of Kyiv / Vestnik Kievskogo Nacional'Nogo Universiteta Imeni Tarasa Ševčenko, 2020, v. 81, n. 2, p. 25, doi. 10.17721/1728_2748.2020.81.25-31
By:
- Stavniichuk, A.;
- Savchuk, O.;
- Khan, Abdul Hye;
- Jankiewicz, Wojciech K.;
- Imig, John D.
Publication type:
Article
А SORAFENIB INDUCED MODEL OF GLOMERULAR KIDNEY DISEASE.
Published in:
Bulletin of Taras Shevchenko National University of Kyiv / Vestnik Kievskogo Nacional'Nogo Universiteta Imeni Tarasa Ševčenko, 2020, v. 81, n. 2, p. 25, doi. 10.17721/1728_2748.2020.81.25-31
By:
- Stavniichuk, A.;
- Savchuk, O.;
- Khan, Abdul Hye;
- Jankiewicz, Wojciech K.;
- Imig, John D.
Publication type:
Article
BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy.
Published in:
BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5556306
By:
- Cao, Weiya;
- Liu, Xueke;
- Zhang, Yinci;
- Li, Amin;
- Xie, Yinghai;
- Zhou, Shuping;
- Song, Li;
- Xu, Ruyue;
- Ma, Yongfang;
- Cai, Shiyu;
- Tang, Xiaolong
Publication type:
Article
Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00677-7
By:
- Perl, Alexander E.;
- Hosono, Naoko;
- Montesinos, Pau;
- Podoltsev, Nikolai;
- Martinelli, Giovanni;
- Panoskaltsis, Nicki;
- Recher, Christian;
- Smith, Catherine C.;
- Levis, Mark J.;
- Strickland, Stephen;
- Röllig, Christoph;
- Groß-Langenhoff, Marco;
- Chou, Wen-Chien;
- Lee, Je-Hwan;
- Yokoyama, Hisayuki;
- Hasabou, Nahla;
- Lu, Qiaoyang;
- Tiu, Ramon V.;
- Altman, Jessica K.
Publication type:
Article
Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia.
Published in:
Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-74168-z
By:
- Santos de Macedo, Brunno Gilberto;
- Albuquerque de Melo, Manuela;
- Pereira-Martins, Diego Antonio;
- Machado-Neto, João Agostinho;
- Traina, Fabíola
Publication type:
Article
Enhanced anticancer activity of silver doped zinc oxide magnetic nanocarrier loaded with sorafenib for hepatocellular carcinoma treatment.
Published in:
Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65235-6
By:
- Khafaga, Doaa S. R.;
- Eid, M. M.;
- Mohamed, Mona H.;
- Abdelmaksoud, Mohamed D. E.;
- Afify, Mie;
- El-Khawaga, Ahmed M.;
- Abdelhakim, Heba K.
Publication type:
Article
Discovery of A Novel Series of Quinazoline–Thiazole Hybrids as Potential Antiproliferative and Anti-Angiogenic Agents.
Published in:
Biomolecules (2218-273X), 2024, v. 14, n. 2, p. 218, doi. 10.3390/biom14020218
By:
- Șandor, Alexandru;
- Fizeșan, Ionel;
- Ionuț, Ioana;
- Marc, Gabriel;
- Moldovan, Cristina;
- Oniga, Ilioara;
- Pîrnău, Adrian;
- Vlase, Laurian;
- Petru, Andreea-Elena;
- Macasoi, Ioana;
- Oniga, Ovidiu
Publication type:
Article
Sorafenib as an Inhibitor of RUVBL2.
Published in:
Biomolecules (2218-273X), 2020, v. 10, n. 4, p. 605, doi. 10.3390/biom10040605
By:
- Nano, Nardin;
- Ugwu, Francisca;
- Seraphim, Thiago V.;
- Li, Tangzhi;
- Azer, Gina;
- Isaac, Methvin;
- Prakesch, Michael;
- Barbosa, Leandro R. S.;
- Ramos, Carlos H. I.;
- Datti, Alessandro;
- Houry, Walid A.
Publication type:
Article
Sorafenib Inhibits Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in Hepatocellular Carcinoma Cells.
Published in:
Biomolecules (2218-273X), 2020, v. 10, n. 1, p. 1, doi. 10.3390/biom10010117
By:
- Pei-Ming Yang;
- Li-Shan Lin;
- Tsang-Pai Liu
Publication type:
Article
Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.
Published in:
2020
By:
- Lai, Yongting;
- Feng, Bing;
- Abudoureyimu, Mubalake;
- Zhi, Yingru;
- Zhou, Hao;
- Wang, Ting;
- Chu, Xiaoyuan;
- Chen, Ping;
- Wang, Rui
Publication type:
Correction Notice
Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells.
Published in:
Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00216
By:
- Chen, Chi-Yuan;
- Chen, Chin-Chuan;
- Chuang, Wen-Yu;
- Leu, Yann-Lii;
- Ueng, Shir-Hwa;
- Hsueh, Chuen;
- Yeh, Chau-Ting;
- Wang, Tong-Hong
Publication type:
Article
Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis.
Published in:
Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2019.01557
By:
- Liu, Lixing;
- Gong, Yang;
- Zhang, Qinglin;
- Cai, Panpan;
- Feng, Li
Publication type:
Article
Investigation of the Prognostic Significance of Vasculogenic Mimicry and Its Inhibition by Sorafenib in Canine Mammary Gland Tumors.
Published in:
Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01445
By:
- Prado, Maria Carolina Mangini;
- Macedo, Sofia de Almeida Losant;
- Guiraldelli, Giulia Gumiero;
- de Faria Lainetti, Patricia;
- Leis-Filho, Antonio Fernando;
- Kobayashi, Priscila Emiko;
- Laufer-Amorim, Renee;
- Fonseca-Alves, Carlos Eduardo
Publication type:
Article
Chidamide Enhances the Cytotoxicity of Cytarabine and Sorafenib in Acute Myeloid Leukemia Cells by Modulating H3K9me3 and Autophagy Levels.
Published in:
Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01276
By:
- Huang, He;
- Wenbing, Yang;
- Dong, Aishu;
- He, Zhewei;
- Yao, Rongxing;
- Guo, Wenjian
Publication type:
Article
Mesothelioma Driver Genes, Ferroptosis, and Therapy.
Published in:
Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01318
By:
- Felley-Bosco, Emanuela;
- Gray, Steven G.
Publication type:
Article
Editorial: Tumor Microenvironment and Resistance to Current Therapies.
Published in:
2019
By:
- Lasfar, Ahmed;
- Balan, Murugabaskar;
- Cohen-Solal, Karine A.;
- Zloza, Andrew
Publication type:
Editorial
Selective Regulation of B-Raf Dependent K-Ras/Mitogen-Activated Protein by Natural Occurring Multi-kinase Inhibitors in Cancer Cells.
Published in:
Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01220
By:
- Abd El Maksoud, Ahmed I.;
- Taher, Rehab F.;
- Gaara, Ahmed H.;
- Abdelrazik, Eman;
- Keshk, Omar S.;
- Elawdan, Khaled A.;
- Morsy, Salwa E.;
- Salah, Ahmed;
- Khalil, Hany
Publication type:
Article
Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.
Published in:
Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01156
By:
- Lai, Yongting;
- Feng, Bing;
- Abudoureyimu, Mubalake;
- Zhi, Yingru;
- Zhou, Hao;
- Wang, Ting;
- Chu, Xiaoyuan;
- Chen, Ping;
- Wang, Rui
Publication type:
Article
The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel–Lindau Disease: A Retrospective Study of 32 Patients.
Published in:
Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01122
By:
- Ma, Kaifang;
- Hong, Baoan;
- Zhou, Jingcheng;
- Gong, Yanqing;
- Wang, Jiangyi;
- Liu, Shengjie;
- Peng, Xiang;
- Zhou, Bowen;
- Zhang, Jiufeng;
- Xie, Haibiao;
- Zhang, Kenan;
- Li, Lei;
- Cai, Desheng;
- Wang, Zixin;
- Cai, Lin;
- Gong, Kan
Publication type:
Article
Safety and Efficacy of Transcatheter Arterial Chemoembolization Plus Radiotherapy Combined With Sorafenib in Hepatocellular Carcinoma Showing Macrovascular Invasion.
Published in:
Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.01065
By:
- Zhao, Yuting;
- Zhu, Xianggao;
- Wang, Hongzhi;
- Dong, Dezuo;
- Gao, Song;
- Zhu, Xu;
- Wang, Weihu
Publication type:
Article
Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular Carcinoma.
Published in:
Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00785
By:
- Michel, Maurice;
- Hollenbach, Marcus;
- Pohl, Sabine;
- Ripoll, Cristina;
- Zipprich, Alexander
Publication type:
Article
High-Affinity Human Anti-c-Met IgG Conjugated to Oxaliplatin as Targeted Chemotherapy for Hepatocellular Carcinoma.
Published in:
Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00717
By:
- Ma, Yilan;
- Zhang, Mingjiong;
- Wang, Jiayan;
- Huang, Xiaochen;
- Kuai, Xingwang;
- Zhu, Xiaojuan;
- Chen, Yuan;
- Jia, Lizhou;
- Feng, Zhenqing;
- Tang, Qi;
- Liu, Zheng
Publication type:
Article
Comparative Efficacy, Safety, and Costs of Sorafenib vs. Sunitinib as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Published in:
Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00479
By:
- Deng, Huan;
- Liu, Wenfeng;
- He, Ting;
- Hong, Zhengdong;
- Yi, Fengming;
- Wei, Yiping;
- Zhang, Wenxiong
Publication type:
Article
Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma.
Published in:
Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00019
By:
- Rizell, Magnus;
- Sternby Eilard, Malin;
- Andersson, Mats;
- Andersson, Bengt;
- Karlsson-Parra, Alex;
- Suenaert, Peter
Publication type:
Article
Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose‐ and time‐dependent manner.
Published in:
Clinical & Experimental Immunology, 2018, v. 193, n. 1, p. 64, doi. 10.1111/cei.13128
By:
- Lohmeyer, J.;
- Nerreter, T.;
- Dotterweich, J.;
- Einsele, H.;
- Seggewiss‐Bernhardt, R.
Publication type:
Article
Dermatoses induced by multikinase inhibitors: A case report.
Published in:
Our Dermatology Online / Nasza Dermatologia Online, 2023, v. 14, n. 2, p. 187, doi. 10.7241/ourd.20232.13
By:
- Preetham, Pottipati;
- Sudha, Selva;
- Kabilan, Nagarajan
Publication type:
Article
Sorafenib promotes hepatocellular carcinoma invasion via interleukin-6/HIF-1a/PFKFB3.
Published in:
Journal of Cancer, 2023, v. 14, n. 10, p. 1859, doi. 10.7150/jca.84451
By:
- Pengyuan Zhuang;
- Dong Wang;
- Kewei Zhang;
- Jiandong Wang;
- Jun Shen
Publication type:
Article
Combination of Metformin and Sorafenib Induces Ferroptosis of Hepatocellular Carcinoma Through p62-Keap1-Nrf2 Pathway.
Published in:
Journal of Cancer, 2022, v. 13, n. 11, p. 3234, doi. 10.7150/jca.76618
By:
- Kezhong Tang;
- Qing Chen;
- Yanmo Liu;
- Lantian Wang;
- Wenjie Lu
Publication type:
Article
YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin.
Published in:
Cellular Oncology (2211-3428), 2021, v. 44, n. 3, p. 689, doi. 10.1007/s13402-021-00595-z
By:
- Sun, Ting;
- Mao, Wenhao;
- Peng, Hui;
- Wang, Qi;
- Jiao, Lin
Publication type:
Article
Strong enhancement by IGF1-R antagonists of hepatocellular carcinoma cell migration inhibition by Sorafenib and/or vitamin K1.
Published in:
Cellular Oncology (2211-3428), 2018, v. 41, n. 3, p. 283, doi. 10.1007/s13402-018-0370-z
By:
- D’Alessandro, Rosalba;
- Refolo, Maria Grazia;
- Lippolis, Catia;
- Carella, Nicola;
- Messa, Caterina;
- Cavallini, Aldo;
- Carr, Brian Irving
Publication type:
Article
Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short report.
Published in:
Cellular Oncology (2211-3428), 2018, v. 41, n. 1, p. 85, doi. 10.1007/s13402-017-0354-4
By:
- Gao, Lixia;
- Shay, Chloe;
- Lv, Fenglin;
- Wang, Xuli;
- Teng, Yong
Publication type:
Article
Efficacy of sorafenib correlates with Memorial Sloan-Kettering Cancer Center (MSKCC) risk classification and bone metastasis in Chinese patients with metastatic renal cell carcinoma.
Published in:
Cellular Oncology (2211-3428), 2016, v. 39, n. 1, p. 15, doi. 10.1007/s13402-015-0245-5
By:
- Zhang, Yushi;
- Li, Yongqiang;
- Cai, Yi;
- Li, Hanzhong;
- Wang, Ke
Publication type:
Article
Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway.
Published in:
Stem Cell Research & Therapy, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13287-022-02888-y
By:
- Takao, Tomoka;
- Masuda, Hirotaka;
- Kajitani, Takashi;
- Miki, Fumie;
- Miyazaki, Kaoru;
- Yoshimasa, Yushi;
- Katakura, Satomi;
- Tomisato, Shoko;
- Uchida, Sayaka;
- Uchida, Hiroshi;
- Tanaka, Mamoru;
- Maruyama, Tetsuo
Publication type:
Article
Indirect Comparisons via Sorafenib for the Comparative Effectiveness of Two PD-1/PD-L1 Inhibitors to Treat Advanced Hepatocellular Carcinoma Patients without Prior Systemic Therapies.
Published in:
Clinical Epidemiology, 2022, v. 14, p. 581, doi. 10.2147/CLEP.S352045
By:
- Jiang, Yawen;
- Cai, Dan;
- Shi, Si
Publication type:
Article
Comparing Safety and Efficacy of TACE + Apatinib in Combination with a PD-1 Inhibitor versus a Non-triple Therapy for Treating Advanced Primary Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Published in:
Journal of Gastrointestinal & Liver Diseases, 2023, v. 32, p. 85, doi. 10.15403/jgld-5159
By:
- Di Pan;
- Haonan Liu;
- Pengfei Qu;
- Xiaoxiao Chen;
- Xiao Ma;
- Yuqin Wang;
- Xiaobing Qin;
- Zhengxiang Han
Publication type:
Article
Complete Remission of Advanced Hepatocellular Carcinoma Treated with Sorafenib and Concomitant Appearance of IgG4-related Diseases. A Case Report.
Published in:
Journal of Gastrointestinal & Liver Diseases, 2021, v. 30, n. 1, p. 142, doi. 10.15403/jgld-1849
By:
- Impellizzeri, Giovanna;
- Renzulli, Matteo;
- Azzaroli, Francesco;
- Golfieri, Rita;
- Mazzella, Giuseppe;
- Marasco, Giovanni
Publication type:
Article
Complete and Sustained Off-Therapy Response to Sorafenib in Advanced Hepatocellular Carcinoma.
Published in:
2016
By:
- Maida, Marcello;
- Macaluso, Fabio Salvatore;
- Valenza, Franco;
- Virdone, Roberto
Publication type:
Case Study
Erratum to: Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.
Published in:
2017
By:
- Liu, Chun-Yu;
- Tseng, Ling-Ming;
- Su, Jung-Chen;
- Chang, Kung-Chi;
- Chu, Pei-Yi;
- Tai, Wei-Tien;
- Shiau, Chung-Wai;
- Chen, Kuen-Feng
Publication type:
journal article
Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02306-4
By:
- Li, Danyang;
- Yao, Yingcheng;
- Rao, Yuhan;
- Huang, Xinyu;
- Wei, Li;
- You, Zhimei;
- Zheng, Guo;
- Hou, Xiaoli;
- Su, Yu;
- Varghese, Zac;
- Moorhead, John F.;
- Chen, Yaxi;
- Ruan, Xiong Z.
Publication type:
Article